Recombinant Human HFABP Protein，His

Heart-type fatty acid-binding protein (HFABP) has garnered significant attention in recent years due to its pivotal role in fatty acid metabolism and its potential as a biomarker for various cardiovascular diseases. HFABP is primarily expressed in cardiac and skeletal muscle tissues, where it facilitates the intracellular transport of fatty acids, thus influencing energy metabolism and cardiac function. Research indicates that elevated levels of HFABP in plasma are associated with heart conditions such as acute myocardial infarction and heart failure, underscoring its diagnostic relevance. The recombinant production of HFABP has become essential for the study of its structure-function relationships, as well as for the development of novel therapeutic strategies targeting lipid metabolism disorders. Moreover, recombinant HFABP allows researchers to investigate its binding properties with various ligands, enabling insights into its conformational dynamics and interactions within metabolic pathways. As obesity and metabolic syndromes continue to rise globally, understanding the biological functions of HFABP through recombinant technologies could lead to innovative approaches in managing cardiovascular health and related metabolic diseases. This growing research landscape emphasizes the need for detailed studies on HFABP to fully capitalize on its therapeutic and diagnostic potential.